|
|
|
|
|
|
|
|
 Thursday's market movers including ValiRx |
|
日期: 13/06/2013 06:52 - 通过: bambaec - 69 意见 - 类别: 各个
The firm has agreed an expanded protocol for its first-in-man studies on VAL 201 - the drug candidate being developed for prostate cancer\nLON:BAO
|
|
评论... |
|
相关视频... |
|
|
|
|
|
|
|
|
|
|
中国的 
